rVSV-based bivalent vaccine against SARS-CoV-2 delta variant

Researchers developed four distinct recombinant vesicular stomatitis virus (rVSV)-based bivalent vaccines against SARS-CoV-2 and influenza virus.

Related Keywords

India , Numstocker Shutterstock , , Recombinant Vesicular Stomatitis Virus , Bivalent Vaccine Against , Image Credit , Coronavirus Disease Covid 19 , Influenza , Cars , Ars Cov 2 , Vaccine , Virus , Antibodies , D4 , Fell , Coronavirus , Ytokine , H1n1 , Immunization , Protein , Public Health , Espiratory , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome ,